Should You Sell 9 Meters Biopharma Inc (NMTR) Stock Thursday?
Thursday, June 30, 2022 12:31 PM | InvestorsObserver Analysts
Mentioned in this article
9 Meters Biopharma Inc (NMTR) stock is down -75.45% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives NMTR stock a score of 28 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 3. NMTR's rank also includes a short-term technical score of 15.
NMTR has an Overall Score of 28. Find out what this means to you and get the rest of the rankings on NMTR!
9 Meters Biopharma Inc (NMTR) stock has fallen -19.41% while the S&P 500 is down -0.23% as of 12:31 PM on Thursday, Jun 30. NMTR is down -$0.06 from the previous closing price of $0.33 on volume of 4,973,037 shares. Over the past year the S&P 500 has fallen -11.35% while NMTR is down -75.45%. NMTR lost -$0.17 per share in the over the last 12 months.
Click Here to get the full Stock Report for 9 Meters Biopharma Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter